October 08, 2026 08:52 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes | ‘He was never wavering while expressing his opinions’: PM Modi mourns Nana Patekar | Nana Patekar dies at 75: Veteran actor suffers cardiac arrest at Goa home | RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50%
Coronavirus Vaccine

Covid vaccine approval likely soon : DCGI

| @indiablooms | Dec 31, 2020, at 11:29 pm

New Delhi/IBNS: The coronavirus vaccines awaiting approval can be cleared soon, India's drug control authority said Thursday.

Drugs Controller General Dr VG Somani said today in a webinar that probably there will be "a happy new year with something in hand".

Somani's assurance came a day ahead of the crucial meeting of the expert panel to authorise emergency use of vaccines made by Serum Institute of India, Bharat Biotech and Pfizer, said reports.

The Centre had formed an expert panel to examine the application of emergency vaccine approval by the drug companies.

Serum Institute is manufacturing Covishield developed by Oxford University and Pharma major AstraZeneca while Bharat Biotech is manufacturing Covaxin partnering with Indian Council of Medical Research (ICMR).

Reports said both the firms have made the presentations before the panel but Pfizer is yet to present the data.

Once cleared by the expert panel, the applications will go to the DCGI for approval. An NDTV report said that officials have said the Oxford vaccine is likely to get approval first.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.